(Q28219359)

English

Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study

scientific article (publication date: 2006)

In more languages

Statements

scholarly article

0 references

Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study (English)

0 references

0 references

author name string

Manoj Sharma

1

0 references

Deepika R Sharma

2

0 references

Vikram Singh

3

0 references

R B Panwar

4

0 references

H S Hira

5

0 references

Bishav Mohan

6

0 references

Naveen Kumar

7

0 references

S K Sharma

8

0 references

Rajeev Gupta

9

0 references

language of work or name

0 references

publication date

2006

0 references

Vascular Health and Risk Management

0 references

2

0 references

1

0 references

87-93

0 references

Obesity, Metabolic Syndrome, and Cardiovascular Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

20 March 2017

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

20 March 2017

Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

20 March 2017

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

7 April 2017

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

7 April 2017

Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

29 September 2017

Statin safety: what to know.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

29 September 2017

Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

29 September 2017

Lipid abnormalities in coronary heart disease: a population-based case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

29 September 2017

Prevention of coronary heart disease among Indians: focus on primary prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

29 September 2017

Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

29 September 2017

Current, new and future treatments in dyslipidaemia and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

29 September 2017

Risk factors for acute myocardial infarction in Indians: a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

29 September 2017

Serum lipid profiles in patients of myocardial infarction in the Chandigarh area (Northern India)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

29 September 2017

Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

2 June 2018

Niacin revisited: clinical observations on an important but underutilized drug.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

2 June 2018

Statins as the cornerstone of drug therapy for dyslipidemia: monotherapy and combination therapy options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

27 November 2018

Apolipoprotein E gene polymorphisms in patients with premature myocardial infarction: a case-controlled study in Asian Indians in North India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

27 November 2018

ACC/AHA/NHLBI clinical advisory on the use and safety of statins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

27 November 2018

Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

27 November 2018

A comparison of cardiovascular risk factors among Indo-Asian and caucasian patients admitted with acute myocardial infarction in Kuala Lumpur, Malaysia and Birmingham, England

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

27 November 2018

Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1993969

27 November 2018

Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins

1 reference

https://api.crossref.org/works/10.2147%2FVHRM.2006.2.1.87

31 March 2020

Correlation of risk factors with coronary angiographic findings in patients of ischaemic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17319473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apolipoproteins A-1 and B as predictors of angiographically assessed coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17319473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of lovastatin (20 mg) and nicotinic acid (1.2 g) with either drug alone for type II hyperlipoproteinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17319473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17319473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2147/VHRM.2006.2.1.87

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28219359&oldid=1398615580"